Johnson & Johnson · NYSE:JNJ
Johnson & Johnson — Fact Sheet (June 2022)
2 slides from Johnson & Johnson's fact sheet, June 2022
Slide 1: Protect Antibiotics, Protect Humanity: Safeguarding Our Medicine for MDR-TB Treatment
Golvensfohmeon Protect Antibiotics, Protect Humanity: Safeguarding Our Medicine for Multidrug-Resistant Tuberculosis (MDR-TB) Treatment Antimicrobial resistance (AMR) is one of the greatest public health threats facing the world today. Due to various factors including overuse and misuse, antibiotics
Slide 2: Antimicrobial stewardship efforts are crucial to ensuring antibiotics are used safely
Antimicrobial stewardship efforts are crucial to ensuring that antibiotics are used safely and correctly and, ultimately, to protect their long- term effectiveness. These include a coherent set of actions promoting responsible stewardship of antibiotics at the individual, national and global levels